Literature DB >> 23578849

Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital.

Chien-Chang Yang1, Po-Chang Hsu, Hong-Jyun Chang, Chun-Wen Cheng, Ming-Hsun Lee.   

Abstract

BACKGROUND: The mortality rate of patients with Clostridium perfringens bacteremia is 27-44%. Typically, the clinical characteristics of this infection are non-specific, which leads to considerable difficulty with the diagnosis and early initiation of appropriate therapy.
METHODS: A retrospective cohort study of patients who were hospitalized between August 2002 and July 2011 with C. perfringens bacteremia was conducted within a 3715-bed teaching hospital in northern Taiwan. The patients identified in this search were included when they had fever or other clinical features suggestive of systemic infection. Multiple logistic regression analysis was applied to determine the independent risk factors of 30-day mortality.
RESULTS: A total of 93 patients were identified. Elderly patients with comorbid illnesses, especially renal insufficiency or malignancy, were at risk of developing C. perfringens bacteremia, and 23 patients (24.7%) had nosocomial bacteremia. The 30-day and attributed mortalities were 26.9% (25/93) and 8.6% (8/93), respectively. Nosocomial infection was a significant predictor for mortality within 30 days (odds ratio 19.378, 95% confidence interval 2.12-176.99; p=0.009), independent of other disease parameters. Other independent risk factors included the Charlson weighted index of comorbidity, length of hospitalization, and stay in the intensive care unit.
CONCLUSIONS: Early recognition of this critical infection and early initiation of appropriate antibiotic treatment by surgical intervention or drainage is essential.
Copyright © 2013 International Society for Infectious Diseases. All rights reserved.

Entities:  

Keywords:  Bacteremia; Clostridium perfringens; Hepatocellular carcinoma; Nosocomial

Mesh:

Substances:

Year:  2013        PMID: 23578849     DOI: 10.1016/j.ijid.2013.03.001

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  24 in total

1.  Clostridium perfringens infection after transarterial chemoembolization for large hepatocellular carcinoma.

Authors:  Jing-Huan Li; Rong-Rong Yao; Hu-Jia Shen; Lan Zhang; Xiao-Ying Xie; Rong-Xin Chen; Yan-Hong Wang; Zheng-Gang Ren
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Gas-forming gluteal abscess after intramuscular self-injections due to Clostridium perfringens.

Authors:  Rafael Garcia-Carretero; Marta Gonzalez-Moreno; Belen Rodriguez-Maya; Elena Isaba-Ares
Journal:  BMJ Case Rep       Date:  2019-02-11

3.  Clostridium perfringens bacteremia associated with colorectal cancer in an elderly woman.

Authors:  Chia-Yu Huang; Mu-Cyun Wang
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

4.  A case of fatal Clostridium perfringens bacteremia and sepsis following CT-guided liver biopsy of a rare neuroendocrine hepatic tumor.

Authors:  Gianluca Landi; Giacomo Gualtieri; Irini Scordi Bello; Daniel Kirsch
Journal:  Forensic Sci Med Pathol       Date:  2017-01-17       Impact factor: 2.007

Review 5.  The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host.

Authors:  George C Stewart
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

6.  Discitis and Clostridium perfringens bacteraemia.

Authors:  Chen Han Yong; Miranda Lam
Journal:  BMJ Case Rep       Date:  2017-07-26

7.  Massive intravascular hemolysis is an important factor in Clostridium perfringens-induced bacteremia.

Authors:  Ai Suzaki; Shihoko Komine-Aizawa; Hiroyuki Nishiyama; Satoshi Hayakawa
Journal:  Intern Emerg Med       Date:  2022-08-13       Impact factor: 5.472

8.  Gas-forming liver abscess associated with rapid hemolysis in a diabetic patient.

Authors:  Miwa Kurasawa; Takashi Nishikido; Junko Koike; Shin-Ichi Tominaga; Hiroyuki Tamemoto
Journal:  World J Diabetes       Date:  2014-04-15

9.  A rare case of non-clostridial infection in a non-diabetic patient.

Authors:  Helin Nie Darat; Avinash Kumar Kanodia; Aiwain Yong; Bhaskar Ram
Journal:  BMJ Case Rep       Date:  2020-01-08

10.  Application of MALDI-TOF MS to assess clinical characteristics, risk factors, and outcomes associated with anaerobic bloodstream infection: a retrospective observational study.

Authors:  Tsuyoshi Watanabe; Yuki Hara; Yusuke Yoshimi; Waka Yokoyama-Kokuryo; Yoshiro Fujita; Masamichi Yokoe; Yoshinori Noguchi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-06-09       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.